Article

American Idol-esque talent competition for young adult survivors gets under way

Author(s):

Melissa Weber

Instead of American Idol or So You Think You Can Dance, young musicians and dancers with cancer now have a competition of their own.Vital Options has launched Surviving Idol: Young Adults with Cancer Expressing Themselves in support of National Young Adult Cancer Awareness Week, which takes place the first week of April. Cancer survivors between ages 17 and 40 can compete in the global talent contest in any of three categories: vocal, instrumental, and dance. A panel of advocates and celebrities affected by cancer will select the finalists in each category, but in true Idol fashion, you vote for your favorites. The winners of Surviving Idol will be featured in an upcoming concert, with other plans in the works as well.The site is still a work in progress, but they're already accepting entries at survivingidol.com.

Related Videos
Image of man with black hair.
Image of Dr. Fakih.
.Dr. Catherine Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston
Image of Doctor with blonde hair.
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based on patient feedback.
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma who have diabetes.
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.
Dr. Neeraj Agarwal is a medical oncologist, a professor of medicine and the Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah, as well as director of the Genitourinary Oncology Program and the Center of Investigational Therapeutics at the Huntsman Cancer Institute in Salt Lake City.
Image of Dr. Goy.
Related Content
Image of water bottle, weights, and apple.
February 22nd 2025

Debunking the Myth That Healthy People Don’t Get Cancer

Jacey Tramutt Amy Schneidmiller-Johnston
The myth that "healthy people don’t get cancer" contributed to my shame, but I’ve learned that cancer can affect anyone, regardless of lifestyle choices.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
Illustration of woman with blonde hair.
February 21st 2025

Cancer is Hard Enough Without Infections

Jane Biehl Ph.D.
As a cancer survivor, I describe battling both cancer and infections and the toll it takes on my body.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Illustration of bladder.
February 21st 2025

Neoadjuvant Chemotherapy Plus Chemoradiation Safe, Effective in Bladder Cancer

Roman Fabbricatore
For some patients with bladder cancer, neoadjuvant chemotherapy plus bladder-saving concurrent chemoradiation therapy was effective in the long term.
Illustration of blood cells.
February 21st 2025

Tuspetinib Triplet Is Safe and Has Antileukemic Activity in Newly Diagnosed AML

Ryan Scott
Treatment with tuspetinib in combination with Venclexta and Vidaza in newly diagnosed acute myeloid leukemia showed safety and antileukemic activity.